YJ6-28205-01933
4 vaccinations
2 coded responses
50 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 232 / VA
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Moderna
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Moderna
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-17
- 2021-04-22
- 2021-04-29
- 2021-05-07
- 2021-05-13
- 2021-05-20
- 2021-07-08
- 2021-10-07
-
2021-11-04
Dose 3 — Moderna
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-11
- 2021-11-18
- 2021-11-27
- 2021-12-02
- 2021-12-09
- 2021-12-16
-
2022-02-03
Survey response — 3 months, dose 3MedDRA: Fatigue, Pyrexia, Sinus congestion, Upper-airway cough syndrome — Feeling: GoodFree text: Post nasal drip, sinus congestion, fatigue, felt feverish.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-05
-
2022-10-07
Dose 4 — Moderna
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-21
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2023-01-06
-
2023-04-07
Survey response — 6 months, dose 4MedDRA: Pre-eclampsia, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationMedDRA releases: 2024-11
-
2023-04-07
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2023-04-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Moderna | |
| 2 | 2021-04-08 | Moderna | |
| 3 | 2021-11-04 | Moderna | No |
| 4 | 2022-10-07 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-07 | Unsuccessful |
Free text
Release 11 — 3 months, dose 3
Symptoms: Post nasal drip, sinus congestion, fatigue, felt feverish.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release